QIAGEN NV (QGEN)
34.58
+0.97
(+2.89%)
USD |
NYSE |
Apr 30, 16:00
34.58
0.00 (0.00%)
Pre-Market: 20:00
QIAGEN Price : 34.58 for April 30, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 2.07 |
| CDT Equity, Inc. | 2.325 |
| LENZ Therapeutics, Inc. | 8.98 |
| Liminatus Pharma, Inc. | 0.2041 |
| Oruka Therapeutics, Inc. | 68.41 |
Price Related Metrics
| PE Ratio | 16.92 |
| PS Ratio | 3.440 |
| PEG Ratio | 0.0404 |
| Price to Book Value | 1.885 |
| Price to Free Cash Flow | 16.08 |
| Earnings Yield | 5.91% |
| Market Cap | 7.123B |
| PEGY Ratio | 0.0393 |
| Operating PE Ratio | 13.78 |
| Normalized PE Ratio | 15.54 |